With a growing interest in SME (Small and Medium Enterprise) IPOs in India, investors are keenly observing promising companies entering the public marketsThough both offer unique accretion pharmaceuticals ipo investment opportunities, they belong to fundamentally different sectors pharmaceuticals and infrastructure each with its own risks and Rewards.
In this blog post, we’ll compare the two IPOs based on company profile, IPO details, financials, industry outlook, and investor appeal to determine which IPO may be a better bet for investors.
1. Company Overview
Accretion Pharmaceuticals Limited operates in the pharmaceutical sector, focusing on innovative drug formulations, R&D, and the manufacturing of APIs and finished dosage forms. The company is known for its commitment to research and therapeutic efficacy, which is a driving force behind its growth.
On the other hand, Integrity Infrabuild Developers Limited operates in the infrastructure and construction sector, specializing in real estate development, civil engineering projects, and public-private Integrity Infrabuild Developers Limited IPO partnership ventures. Their projects typically include commercial buildings, roads, and other urban development projects.
2. Integrity Infrabuild
Developers IPO Features.
Integrity Infrabuild Developers Ltd is set to launch its IPO from May 13 to May 15, 2025, offering 12,00,000 equity shares with a face value of ₹10 each. The expected issue price is ₹100 per share, and the listing date is scheduled for May 20, 2025.
IPO Overview
• IPO Opening Date: May 13, 2025
• IPO Closing Date: May 15, 2025
• Listing Date: May 20, 2025
• Face Value: ₹10 per share
• Issue Price: ₹100 per share
• Total Shares Offered: 12,00,000 equity shares.
Use of Proceeds
• Funds raised will be utilized for:
• Equipment purchase
• Debt repayment
Company Profile
• Sector: General construction
• Focus Areas: Roads, highways, and bridges
• Order Book: ₹3,092 crore
Additional Information
• Market Exchanges: BSE and NSE.
3. Accretion Pharmaceuticals IPO Features.
Accretion Pharmaceuticals Ltd is preparing for its IPO, which will take place from May 14 to May 16, 2025. The company plans to offer 29,46,000 equity shares with a price range set between ₹96 and ₹101 per share. shares are expected to be listed on May 21, 2025.
IPO Overview
• IPO Opening Date: May 14, 2025
• IPO Closing Date: May 16, 2025
• Listing Date: May 21, 2025
• Face Value: ₹10 per share
• Issue Price at : ₹96 – ₹101 per share
• Total Shares Offered: 29,46,000 equity shares
• Lot Size: 1,200 shares (Minimum Investment: ₹121,200)
Use of Proceeds
• The funds raised through this IPO will be allocated for:
• Business expansion initiatives
• Enhancing working capital
Company Profile
• Sector: Pharmaceuticals
• Focus Areas: Drug development, manufacturing, and innovative healthcare solutions.
4. Accretion Pharmaceuticals IPO – Growth in the Healthcare Sector.
Accretion Pharmaceuticals operates in the dynamic pharmaceutical industry, offering long-term growth prospects. The rising demand for affordable healthcare, increasing drug innovation, and government support for the healthcare sector position the company for potential expansion. However, pharma businesses often require time to generate substantial profits due to regulatory processes and research expenses. This IPO is suitable for investors who are looking to bet on innovation and can wait for longer-term returns.
5. Integrity Infrabuild Developers IPO – Stability Through Infrastructure.
Integrity Infrabuild Developers Limited is a government-focused civil contractor with a strong track record in public infrastructure projects. Its business is rooted in steady government orders for roads, buildings, and bridges. Backed by a ₹163 crore order book and 100+ completed projects, the company shows promise in consistent revenue generation. This IPO may appeal more to conservative investors who prioritize stable income and lower market volatility.
Conclusion
For aggressive investors who prefer growth potential in healthcare and biotech, Accretion Pharmaceuticals might be the right pick. For those seeking reliable earnings and reduced risk, Integrity Infrabuild Developers offers more safety. Ultimately, the better IPO depends on your investment style, NSE sector interest, and risk appetite.
